Cargando…
Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
The fascinating similarity between the SARS-CoV and SARS-CoV-2, inspires scientific community to investigate deeper into the SARS-CoV proteases such as main protease (Mpro) and papain-like protease (PLpro) and their inhibitors for the discovery of SARS-CoV-2 protease inhibitors. Because of the simil...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880840/ https://www.ncbi.nlm.nih.gov/pubmed/33618158 http://dx.doi.org/10.1016/j.ejmech.2021.113294 |